APA (7th ed.) Citation

IS, P., JH, K., D, K., YW, K., Y, S., KB, K., . . . JH, C. (2026). CU104, a novel barrier function enhancer, improves colitis via modulation of barrier function and immune cell recruitment. Frontiers in immunology, 17, 1767762. https://doi.org/10.3389/fimmu.2026.1767762

Chicago Style (17th ed.) Citation

IS, Park, et al. "CU104, a Novel Barrier Function Enhancer, Improves Colitis via Modulation of Barrier Function and Immune Cell Recruitment." Frontiers in Immunology 17 (2026): 1767762. https://doi.org/10.3389/fimmu.2026.1767762.

MLA (9th ed.) Citation

IS, Park, et al. "CU104, a Novel Barrier Function Enhancer, Improves Colitis via Modulation of Barrier Function and Immune Cell Recruitment." Frontiers in Immunology, vol. 17, 2026, p. 1767762, https://doi.org/10.3389/fimmu.2026.1767762.